These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3181218)

  • 1. Plasma levels of fluphenazine and prolactin in psychiatric patients.
    Kitamura T; McGovern DA; Imlah NW; Wiles D; Schiff AA
    Eur Arch Psychiatry Neurol Sci; 1988 Sep; 237(6):320-6. PubMed ID: 3181218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Br J Clin Pharmacol; 1979 Dec; 8(6):565-70. PubMed ID: 533577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
    Chang SS; Javaid JI; Dysken MW; Casper RC; Janicak PG; Davis JM
    Psychopharmacology (Berl); 1985; 87(1):55-8. PubMed ID: 3933037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
    Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U
    Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
    Norman TR; Marriott PF; Kimber NM; Burrows GD
    Int Clin Psychopharmacol; 1987 Oct; 2(4):299-305. PubMed ID: 3693869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection.
    Glazer WM; Friedhoff LT; Marder SR; Brown WA
    Schizophr Res; 1992 Dec; 8(2):111-7. PubMed ID: 1457388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Wiles DH; McCreadie RG; Whitehead A
    Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot fluphenazine and plasma prolactin.
    Gift T; Plum K; Price M
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):407-12. PubMed ID: 4070643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine decanoate in acute and maintenance therapy of schizophrenia.
    Altamura AC; Mauri MC; Guercetti G; Cazzullo CL
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):613-23. PubMed ID: 3122268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys.
    Linn GS; Lifshitz K; O'Keeffe RT; Lee K; Camp-Lifshitz J
    Psychopharmacology (Berl); 2001 Jan; 153(3):285-94. PubMed ID: 11271400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA; Silver MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
    Marder SR; Aravagiri M; Wirshing WC; Wirshing DA; Lebell M; Mintz J
    Schizophr Res; 2002 Jan; 53(1-2):25-30. PubMed ID: 11728835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine.
    Dencker SJ; Johansson R; Malm U
    Psychopharmacology (Berl); 1988; 94(2):237-41. PubMed ID: 3127851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
    Altamura AC; Curry SH; Montgomery S; Wiles DH
    Psychopharmacology (Berl); 1985; 87(1):30-3. PubMed ID: 3933035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The plasma prolactin level under fluphenazine treatment (author's transl)].
    Hinterhuber H; Platz T; Schwarz S
    Wien Med Wochenschr; 1980 Sep; 130(17):566-70. PubMed ID: 7456470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fluphenazine on basal prolactin concentrations.
    Chalmers RJ; Bennie EH
    Psychol Med; 1978 Aug; 8(3):483-6. PubMed ID: 704714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
    Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J
    Br J Psychiatry; 1991 May; 158():658-65. PubMed ID: 1860020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.